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CASE REPORT
Radiotherapy for lung metastases in a patient with Ewing sarcoma
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Center of Oncoradiology, Uzsoki Hospital, H-1145 Budapest, Uzsoki u. 29, Hungary
Abstract
Purpose. To assess the bene® t of therapy for multiple lung metastases in a young female patient previously treated with
operation, local radiotherapy and chemotherapy.
Patient: Lung metastases occurred in a young female patient 13 months after ® nishing combined treatment of a Ewing
sarcoma of the left eleventh rib. Primary treatment had included surgical removal, 51 Gy local radiotherapy and
chemotherapy.
Method. 20 Gy total dose was applied to the lungs of both sides in two courses with an additional 15 Gy to the
mediastinum.
Results and Discussion. Complete radiological regression was achieved at the end of therapy which was maintained during
the follow-up period of 16 months.
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Introduction
Ewing sarcoma is the second most frequent bone
tumour among children and young adults. Com-
prises 10± 15% of all bone tumors. It rarely occurs
under the age of 5 or above the age of 30. The male
to female ratio is 1.5:1.
Ewing sarcoma arises intramedullary, breaks
through the cortex and extend as a soft tissue mass.
Virtually any bone can be the site of the primary
lesion, but the lower half of the body is much more
frequently involved than the upper half. The fre-
quency of rib involvement follows that of the femur,
the pelvic bones, the ® bula, the humerus and the
tibia. It has a moderately bad prognosis.
1± 3 Distant
metastases are frequent to the lungs and other
bones. Metastatic involvement of lymph nodes oc-
curs in less than 10% of cases. Increasing pain,
swelling and fever are the leading clinical symptoms.
Plain X-ray with bone and bone marrow scintigra-
phy demonstrate primary or secondary skeletal in-
volvement. Computed tomography (CT) and MRI
are informative for the judgement of periosteal and
the intramedullary extension.
2
Diagnosis
A 29-year-old female patient presented with increas-
ing back pain on the left side, effort dyspnoea and
fever. Chest X-ray showed a palm-sized
supraphrenic in® ltration on the left with minimal
pleural effusion. Laboratory parameters were
normal except for a raised sedimentation rate and
leucocytosis. Pneumonia was suspected and anti-
biotic treatment started but dyspnoea and the level
of the pleural effusion increased. Cytology of the
pleural ¯ uid suggested in¯ ammation but further X-
ray showed extensive con¯ uent rarefaction of the
XIth rib with bone destruction. Whole body bone
and bone marrow scan showed no changes else-
where.
Primary treatment
After resection of the involved rib, histopathological
examination (including immuno-histochemistry)
gave the diagnosis of Ewing sarcoma. Postoperative
radiochemotherapy was commenced in June 1994.
The chemotherapy comprised 6 courses of VIP (200
mg Vepeside, 800 mg Ifosfamide, 60 mg Cisplatin,
with Uromitexan rescue). Radiotherapy was deliv-
ered after the ® rst course of chemotherapy (51 Gy
locally with a high-energy electron beam). The ® rst
course of chemotherapy had to be interrupted be-
cause of dysuria. Colony stimulating factor was
necessary because of leukopenia after further
courses.
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Fig. 1. Plain X-ray before pulmonary irradiation.
Fig. 2. CT scan before pulmonary irradiation.Radiotherapy for lung metastases in Ewing sarcoma 211
Complementary mediastinal irradiation was given
after a six weeks interruption, with 15 Gy mid-plane
were applied via central-symmetrically positioned,
opposed portals in 1.5 Gy fractions.
Prophylactic irradiation of the right hemithorax
was started 4 weeks after the mediastinal irradiation.
20 Gy total mid plane dose was applied in 1.5 Gy
fractions. The mediastinal treated volume over-
lapped to its half width with the left and right
hemithorax volumes for increasing the total dose in
the mediastinum. Matching problems are clinically
negligible at these magnitudes of total dose if ap-
plied sequentially to these regions (Fig. 3).
The overall treatment took 23 weeks including
the breaks. Complete remission (plain X-ray and
CT) lasted for 16 months (Figs 4 and 5).
Local recurrence appeared in the left lumbal area
near to the resection site. CT showed a 40 3 75 mm
mass involving the end of the resected XIth rib
in® ltrating the musculature between the left kidney
and spleen. An additional 30 Gy was applied and
resulted in complete remission of the recurrence.
Discussion
Metastasising Ewing sarcoma is associated with
short term remission and survival but pulmonary
irradiation may prove effective.
4± 9
Data are available concerning the prophylactic
and therapeutic use of pulmonary irradiation in
patients with Ewing sarcoma. Prophilactically total
doses of 1500± 1800 cGy were applied in 150± 200
cGy daily fractions within 2.5± 3 weeks.
2,10 Doses of
the magnitude plus chemotherapy resulted in pro-
longed disease free survival and prolonged survival
in the IESS-I study versus chemotherapy alone.
2
Therapeutically the same total doses plus local boost
were applied to 2000± 2500 cGy
10,11 resulting in
complete plus partial remission rates 77%.
11 Pul-
monary metastases were inoperable in this young
female patient. Primary chemotherapy were associ-
ated with severe side effects, although radiation
therapy was well tolerated. The left hemithorax and
the lower posterior mediastinum were irradiated
with the aim of achieving therapeutic effect on man-
ifest multiple lesions. Nevertheless we did the same
for prophylactic purposes on the uninvolved right
hemithorax. The reasons for the choice of this care-
ful, sequential approach were the following:
· multiple, extensive lesions on the involved left
side and therefore palliative aim;
· primary combined treatment was associated with
haematological side effects;
· better radiation tolerance of the lung with partial
volume-exposure; and
· special importance of the right lung in the respir-
atory function in case of massive contralateral
impairment.
Sequential irradiation of the hemithorax on both
Fig. 3. Treatment scheme: ® rst phase: portals 1 and 2, left
hemithorax; second phase: portals 3 and 4, mediastinum; and
third phase: portals 5 and 6, right hemithorax.
Treatment of the pulmonary metastases
She remained symptom free for 13 months, with
complete remission documented by CT. After the
onset of cough pulmonary metastases were shown
on thoracic X-ray and CT. Multiple rounded opac-
ities were found: paracardic anteriorly 7 cm, retro-
cardiac 8 cm, lateral to the left hilus 6 cm, in the left
apex along the thoracic wall on the pleura 8 cm, and
above the arch of aorta along the mediastinal pleura
3 cm in diameter. The right lung showed no abnor-
mality (Figs 1 and 2).
Whole-thorax irradiation was performed in three
phases. An effective palliation was the aim of ther-
apy in this case, so the left hemithorax was treated
® rst. After experiencing the very rapid regression of
the multiple lesions in this site, treatment was ex-
tended to the neighbouring structures at risk, i.e.
mediastinal and prophylactic right hemithorax ir-
radiation was performed in the following two treat-
ment phases. 20 Gy total mid-plane dose was
applied to the involved left hemithorax from a tele-
cobalt unit with slightly angled anterior and pos-
terior portals using 1.5 Gy fractions. The anterior
® eld was tilted 10 degrees laterally and the posterior
® eld 15 degrees medially. This slight tilting enabled
the paravertebral entering of the medial edge of the
posterior portal with respect to the better protection
of the spinal cord after previous chemotherapy.
Three weeks later plain X-ray showed complete
remission of the metastases on the left side.212 A. Kegye & A. Nasza Â ly
Fig. 4. Plain X-ray 3 months after the ® nishing irradiation with a total dose of 20 Gy to the left hemithorax.
Fig. 5. CT scan demonstrating total remission 3 months after the ® nishing irradiation with a total dose of 20 Gy to the left hemithorax.
sides and mediastinum may involve more matching
problems than chest irradiation of the two sides at
the same time, but the space of time between the
treatment phases and the described ® eld arrange-
ment contribute to decrease them at low doses. The
outpatient treatment led to radiological complete
remission and improvement in quality of life without
dyspnoea. She has been symptom free for 16
months after ® nishing therapy and is able to pursue
some sport.Radiotherapy for lung metastases in Ewing sarcoma 213
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